| scholarly article | Q13442814 |
| P50 | author | Alistair Scott Hall | Q37624871 |
| Karthik Viswanathan | Q57627342 | ||
| P2093 | author name string | Mohan U Sivananthan | |
| Julian H Barth | |||
| Christine Morrell | |||
| Niamh Kilcullen | |||
| Tajek B Hassan | |||
| Sue J Thistlethwaite | |||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fatty acid | Q61476 |
| patient | Q181600 | ||
| acute coronary syndrome | Q266018 | ||
| P304 | page(s) | 2590-2598 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative | |
| P478 | volume | 55 |
| Q35771734 | An evidence-based approach to the assessment of heart-type Fatty Acid binding protein in acute coronary syndrome. |
| Q33644456 | Association of heart-type fatty acid-binding protein with cardiovascular risk factors and all-cause mortality in the general population: the Takahata study |
| Q38852297 | Asymmetric dimethylarginine and heart-type fatty acid-binding protein 3 are risk markers of cardiotoxicity in carbon monoxide poisoning cases in Zagazig university hospitals |
| Q26778588 | Beyond the Limits: Clinical Utility of Novel Cardiac Biomarkers |
| Q37994306 | Biomarkers in acute myocardial injury |
| Q35634229 | Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction. |
| Q36186070 | Cardiogoniometry as a diagnostic tool in patients with acute coronary syndromes: results of the CGM@ACS trial. |
| Q92811812 | Circulating biomarkers in chronic thromboembolic pulmonary hypertension |
| Q46188463 | Clinical and analytical evaluation of an immunoturbidimetric heart-type fatty acid-binding protein assay |
| Q42200250 | Comparative study of high sensitivity troponin T and heart-type fatty acid-binding protein in STEMI patients |
| Q44325501 | Comparison of contemporary troponin assays with the novel biomarkers, heart fatty acid binding protein and copeptin, for the early confirmation or exclusion of myocardial infarction in patients presenting to the emergency department with chest pain |
| Q42756712 | Diabetic patients have increased perioperative cardiac risk in heart-type fatty acid-binding protein-based assessment |
| Q33773201 | Diagnostic accuracy of heart fatty acid binding protein (H-FABP) and glycogen phosphorylase isoenzyme BB (GPBB) in diagnosis of acute myocardial infarction in patients with acute coronary syndrome |
| Q51837358 | Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study. |
| Q55030658 | Fatty acid binding protein 3 is associated with skeletal muscle strength in polymyositis and dermatomyositis. |
| Q86359969 | H-FABP, cardiovascular risk factors, and functional status in asymptomatic spinal cord injury patients |
| Q36614485 | Heart type fatty acid binding protein response and subsequent development of atherosclerosis in insulin resistant polycystic ovary syndrome patients. |
| Q54978892 | Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis. |
| Q35038410 | Heart-type fatty acid binding protein (H-FABP): relationship with arterial intima-media thickness and role as diagnostic marker for atherosclerosis in patients with ımpaired glucose metabolism |
| Q36323910 | Heart-type fatty acid binding protein and high-sensitivity troponin T are myocardial damage markers that could predict adverse clinical outcomes in patients with peripheral artery disease |
| Q38247939 | Heart-type fatty acid binding protein in early diagnosis of myocardial infarction in the era of high-sensitivity troponin: a systematic review and meta-analysis |
| Q47101034 | Heart-type fatty acid binding protein levels in elderly diabetics without known cardiovascular disease |
| Q51027112 | Increase in skin autofluorescence and release of heart-type fatty acid binding protein in plasma predicts mortality of hemodialysis patients. |
| Q50850621 | Incremental value of heart-type fatty acid-binding protein in suspected acute myocardial infarction early after symptom onset |
| Q38138158 | Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids. |
| Q35662925 | Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I. |
| Q45370584 | Mid-regional pro-atrial natriuretic peptide as a prognostic marker for all-cause mortality in patients with symptomatic coronary artery disease |
| Q87913144 | Monocyte subsets and monocyte-platelet aggregates in patients with unstable angina |
| Q38714511 | Novel Biomarkers of Subclinical Cardiac Dysfunction in the General Population |
| Q36016656 | Perioperative heart-type fatty acid binding protein is associated with acute kidney injury after cardiac surgery |
| Q36943516 | Perioperative heart-type fatty acid binding protein levels in atrial fibrillation after cardiac surgery |
| Q28072708 | Prognostic Significance of Right Bundle Branch Block for Patients with Acute Myocardial Infarction: A Systematic Review and Meta-Analysis |
| Q44484688 | Prognostic impact of the serum heart-type fatty acid-binding protein (H-FABP) levels in patients admitted to the non-surgical intensive care unit. |
| Q89635437 | Prognostic utility of heart-type fatty acid-binding protein in patients with stable coronary artery disease and impaired glucose metabolism: a cohort study |
| Q34694790 | Taking a new biomarker into routine use--a perspective from the routine clinical biochemistry laboratory |
| Q53306185 | Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine. |
| Q39017422 | The Prognostic Value of Heart Type Fatty Acid Binding Protein in Patients with Suspected Acute Coronary Syndrome: A Systematic Review |
| Q37084130 | The Prognostic Value of Serum Levels of Heart-Type Fatty Acid Binding Protein and High Sensitivity C-Reactive Protein in Patients With Increased Levels of Amino-Terminal Pro-B Type Natriuretic Peptide |
| Q41838649 | The association between defibrillation shock energy and acute cardiac damage in patients with implantable cardioverter defibrillators |
| Q21245453 | The human fatty acid-binding protein family: evolutionary divergences and functions |
| Q36123371 | The serum heart-type fatty acid-binding protein (HFABP) levels can be used to detect the presence of acute kidney injury on admission in patients admitted to the non-surgical intensive care unit. |
| Q26829746 | The year in non-ST-segment elevation acute coronary syndrome |
| Q36515778 | Troponin T and Heart Type Fatty Acid Binding Protein (h-Fabp) as Biomarkers in Patients Presenting with Chest Pain. |
| Q83474563 | [Cardiac biomarkers in the critically ill] |
| Q22242895 | ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el |
Search more.